Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Depreciation & Amortization (CF) (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Depreciation & Amortization (CF) for 2 consecutive years, with $527000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) fell 27.91% to $527000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $2.2 million, a N/A change, with the full-year FY2024 number at $3.0 million, up 54.75% from a year prior.
  • Depreciation & Amortization (CF) was $527000.0 for Q3 2025 at Pyxis Oncology, down from $535000.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $1.1 million in Q1 2024 to a low of $527000.0 in Q3 2025.